These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1972427)

  • 1. [Clinical significance of blood group antigen in sera as a tumor marker].
    Imai K; Arimura Y; Yachi A
    Nihon Rinsho; 1990 Feb; 48 Suppl():912-6. PubMed ID: 1972427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of 2-6 sialyl Le(a) antigen assay as a tumor marker].
    Kannagi R; Itai S; Harada R
    Nihon Rinsho; 1990 Feb; 48 Suppl():1045-52. PubMed ID: 2355503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of Lewis blood-group phenotype and serum CA-19-9 analysis in the diagnosis of diabetic diseases].
    Shimojo N; Okuda K
    Nihon Rinsho; 1990 Dec; 48 Suppl():359-64. PubMed ID: 2086909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of glycolipid analysis in clinical tests].
    Senba U; Okabe H
    Nihon Rinsho; 1989 Dec; 48 Suppl():529-33. PubMed ID: 2516152
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum diagnosis of cancer with monoclonal antibodies].
    Kannagi R
    Rinsho Byori; 1989 Jul; (Spec No 82):52-86. PubMed ID: 2575677
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.
    Pour PM; Tempero MM; Takasaki H; Uchida E; Takiyama Y; Burnett DA; Steplewski Z
    Cancer Res; 1988 Oct; 48(19):5422-6. PubMed ID: 3166398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2 --> 6 sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():703-8. PubMed ID: 20960854
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemistry and histochemistry of new tumor-associated antigens and their relation to blood group substances].
    Vierbuchen M; Larena A; Hanisch FG; Uhlenbruck G
    Verh Dtsch Ges Inn Med; 1991; 97():420-49. PubMed ID: 1808924
    [No Abstract]   [Full Text] [Related]  

  • 9. [New clinical tests: current status of tumor markers].
    Imai K; Taniuchi A
    Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):554-7. PubMed ID: 7688018
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
    Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
    Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological significance of tumor marker].
    Ochi Y
    Rinsho Byori; 1985 Aug; 33(8):831-8. PubMed ID: 3908745
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of sialyl SSEA-1 assay as a tumor marker].
    Endo J; Nagaoka S; Kannagi R
    Nihon Rinsho; 1990 Feb; 48 Suppl():1008-12. PubMed ID: 1972417
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues.
    Tsuboi K; Asao T; Ide M; Hashimoto S; Noguchi K; Kominato Y; Saniabadi AR; Kuwano H; Yazawa S
    Ann Surg Oncol; 2007 Jun; 14(6):1880-9. PubMed ID: 17375356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
    Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
    Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood group antigens as differentiation and tumor-associated markers in oral epithelium.
    Dabelsteen E; Mandel U; Clausen H
    Proc Finn Dent Soc; 1988; 84(1):19-29. PubMed ID: 3283734
    [No Abstract]   [Full Text] [Related]  

  • 16. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
    Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
    Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current concept of tumor markers in oncological urology--cell surface markers].
    Ianev V; Kumanov Kh; Tsvetkov D; Ormanov I
    Khirurgiia (Sofiia); 1989; 42(4):14-7. PubMed ID: 2585974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing of urine in the ABO and Lewis systems.
    Kotowski TM
    J Forensic Sci; 1987 Jul; 32(4):1065-8. PubMed ID: 3475403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in lung cancer.
    Lee JS; Hong WK
    N Engl J Med; 1992 Jul; 327(1):47-8. PubMed ID: 1317942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.